Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01056380 · ClinicalTrials.gov registry record · Phase 2
Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza
A Phase 2 study, sponsored by Romark Laboratories L.C..
- Terminated
- Registry status
- Phase 2
- Development phase
- 79
- Enrollment target
NCT01056380 is a Phase 2 study that was terminated before completion, run by Romark Laboratories L.C.. The registered enrollment target is 79 participants.
The verdict
NCT01056380, a Phase 2 study, was terminated before completion, sponsored by Romark Laboratories L.C..
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 79 participants
- Enrollment target
Study Summary
This is a randomized clinical trial designed to evaluate oral nitazoxanide compared to a placebo in the treatment of acute uncomplicated influenza in adults. We hypothesize that treatment with nitazoxanide will reduce the duration of symptoms in patients with confirmed influenza infection. Secondarily, we hypothesize that treatment with nitazoxanide will reduce the complications of influenza, severity of symptoms, time lost from work, time to return to normal daily activities, and viral shedding.
Interventions
- DRUG Placebo
- DRUG Nitazoxanide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2010-01 |
| Est. Completion | 2010-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01056380
The ClinicalTrials.gov registry entry for NCT01056380 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Romark Laboratories L.C., which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01056380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01056380 about?
NCT01056380 is a clinical study titled "Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza". This is a randomized clinical trial designed to evaluate oral nitazoxanide compared to a placebo in the treatment of acute uncomplicated influenza in adults. We hypothesize that treatment with nitazoxanide will reduce the duration of symptoms in patients with confirmed influenza infection. Secondari...
What is the current status of trial NCT01056380?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 79 participants. The study started on 2010-01. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01056380?
The interventions under investigation include: Placebo (DRUG), Nitazoxanide (DRUG).
Who is sponsoring clinical trial NCT01056380?
This trial is sponsored by Romark Laboratories L.C., which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.